质母细胞瘤中IL-6是微环境免疫抑制和对治疗的抵抗的基础
Jacob S Young1, Nam Woo Cho2,3,4,5, Calixto-Hope G Lucas6,7,8
1Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA.
bioRxiv : the preprint server for biology
|March 31, 2025
概括
干白素-6 (IL-6) 抑制可以克服质母细胞瘤中的免疫抑制性瘤免疫微环境 (TIME),增强对免疫检查点抑制 (ICI) 和放射治疗的反应.
科学领域:
- 神经瘤学神经瘤学
- 免疫学 免疫学 免疫学
- 癌症治疗 癌症治疗
背景情况:
- 质母细胞瘤的瘤免疫微环境 (TIME) 是免疫抑制的,限制了治疗疗效,特别是免疫检查点抑制 (ICI).
- 质母细胞瘤的关键特征包括免疫抑制性细胞因子,前瘤髓状细胞和耗尽的T细胞.
研究的目的:
- 调查介质素-6 (IL-6) 在质母细胞瘤中的作用以及其作为治疗点的潜力.
- 为了确定IL-6抑制是否可以使质母细胞瘤对免疫检查点抑制 (ICI) 和放射治疗敏感.
主要方法:
- 在ICI前后对人类质母细胞瘤样本进行空间和单细胞分析的整合.
- 在小鼠模型中使用遗传,免疫学,单细胞和药理学方法的临床前研究.
- 评估IL-6阻塞与ICI和放射治疗的结合.
主要成果:
- 在治疗前较低的IL-6水平与人类质母细胞瘤患者对ICI的临床反应相关.
- 在小鼠中,IL-6抑制重新编程了质母细胞瘤的时间,增加了有益的免疫细胞 (单细胞,树突细胞,CD8+ T细胞) 并减少了抑制Tregs.
- IL-6阻塞使小鼠质母细胞瘤对ICI和放射治疗敏感,从而改善了生存率.
结论:
- IL-6是质母细胞瘤免疫抑制时间的关键因素,也是潜在的治疗点.
- 抑制IL-6可以增强质母细胞瘤对ICI和放射治疗的敏感性,为复发性质母细胞瘤提供了一个有希望的组合策略.
相关概念视频
02:17The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
01:27Tumor Immunotherapy
432
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
432